Pulmonx Corporation (LUNG) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	87.4M	90.5M	83.8M	68.7M	53.7M
Cost of Revenue	20.1M	23.4M	21.8M	17.9M	13.8M
Gross Profit	67.4M	67.1M	62.0M	50.8M	39.9M
Operating Expenses
R&D Expense	19.4M	19.5M	17.6M	18.1M	15.4M
SG&A Expense	94.3M	101.3M	102.1M	94.6M	83.1M
General & Admin Expense	—	—	94.2M	89.8M	—
Selling & Marketing Expense	—	—	7.9M	4.8M	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	113.7M	120.8M	119.7M	112.7M	98.5M
Cost and Expenses	133.8M	144.2M	141.5M	130.6M	112.3M
Operating Income (EBIT)	(46.3M)	(53.7M)	(57.7M)	(61.9M)	(58.6M)
Non-Operating
Interest Income	1.7M	2.7M	5.1M	5.6M	1.5M
Interest Expense	3.8M	3.2M	3.5M	3.2M	1.1M
Net Interest Income	(2.0M)	(504.0K)	1.6M	2.3M	463.0K
Other Non-Op Income/Expense	(1.2M)	286.0K	1.8M	1.7M	67.0K
Non-Operating Income (excl Interest)	(2.6M)	(3.4M)	(5.3M)	(4.9M)	(1.1M)
EBT (Pre-Tax Income)	(47.5M)	(53.4M)	(55.9M)	(60.3M)	(58.6M)
Income Tax Expense	596.0K	626.0K	500.0K	571.0K	353.0K
Bottom Line
Net Income	(48.1M)	(54.0M)	(56.4M)	(60.8M)	(58.9M)
Earnings from Cont. Ops	(48.1M)	(54.0M)	(56.4M)	(60.8M)	(58.9M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(48.1M)	(54.0M)	(56.4M)	(60.8M)	(58.9M)
Per Share
Basic EPS	($1.15)	($1.33)	($1.44)	($1.60)	($1.59)
Diluted EPS	($1.15)	($1.33)	($1.44)	($1.60)	($1.59)
Revenue Per Share	$2.07	$2.22	$2.14	$1.81	$1.45
Shares
Basic Shares Outstanding	42.2M	40.7M	39.1M	38.0M	37.1M
Diluted Shares Outstanding	42.2M	40.7M	39.1M	38.0M	37.1M
Profitability Metrics
EBITDA	(43.1M)	(49.2M)	(50.8M)	(55.1M)	(56.0M)
D&A	697.0K	1.1M	1.6M	1.9M	1.5M
EBIT	(43.8M)	(50.2M)	(52.4M)	(57.0M)	(57.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026